David Martin
机构:Moderna Therapeutics (United States) · ORCID:0000-0003-4517-0380
发表论文 128 篇 · 总被引 4646 次 · h-index 30
代表论文
- Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses (2023 · JAMA · 被引 401)
- Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions (2022 · Nature Communications · 被引 115)
- Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults (2023 · Vaccines · 被引 34)
- Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United States (2024 · Open Forum Infectious Diseases · 被引 26)
- Relative Effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines and Homologous Boosting in Preventing COVID-19 in Adults in the US (2023 · Open Forum Infectious Diseases · 被引 21)
- Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States (2024 · Infectious Diseases and Therapy · 被引 18)